Your search returned 10 results.

Results
	1.	Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of (131)I. MedStar authors: Atkins, Francis Burman, Kenneth D Moreau, Shari Van Nostrand, Douglas Wartofsky, Leonard PMID: 26357962 Year: 2015 Citation: Thyroid. 25(12):1347-50, 2015 Dec. Institution: MedStar Washington Hospital Center MedStar Washington Hospital Center MedStar Washington Hospital Center MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Endocrinology Medicine/Nuclear Medicine Medicine/Nuclear Medicine Medicine/Nuclear Medicine Medline publication type: Journal Article Research Support, Non-U.S. Gov't Validation Studies Form of publication: Journal Article All authors: Atkins F, Burman K, Moreau S, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.1089/thy.2014.0616 Add to cart (remove)
	2.	Effects of Dosimetrically Guided I-131 Therapy on Hematopoiesis in Patients With Differentiated Thyroid Cancer. MedStar authors: Atkins, Francis Bikas, Athanasios Burman, Kenneth D Desale, Sameer Mete, Mihriye Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard PMID: 26900639 Year: 2016 Citation: Journal of Clinical Endocrinology & Metabolism. 101(4):1762-9, 2016 Apr Institution: MedStar Health Research Institute MedStar Heart & Vascular Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Atkins F, Bikas A, Burman KD, Desale S, Mete M, Schneider M, Van Nostrand D, Wartofsky L DOI: https://dx.doi.org/10.1210/jc.2015-3544 Add to cart (remove)
	3.	Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. MedStar authors: Atkins, Francis Garcia, Carlos Van Nostrand, Douglas PMID: 28104741 Year: 2017 Citation: Journal of Nuclear Medicine. 58(7):1146-1154, 2017 Jul Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Atkins F, Garcia C, Hobbs RF, Huang K, Plyku D, Sgouros G, Van Nostrand D DOI: https://dx.doi.org/10.2967/jnumed.116.179366 Add to cart (remove)
	4.	Optimal Time for 124I PET/CT Imaging in Metastatic Differentiated Thyroid Cancer. MedStar authors: Atkins, Francis Burman, Kenneth D Garcia, Carlos Kulkarni, Kanchan Plyku, Donika Tefera, Eshetu Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 33492859 Year: 2021 Citation: Clinical Nuclear Medicine. 2021 Jan 21 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Atkins F, Burman KD, Garcia C, Kulkarni K, Plyku D, Tefera E, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.1097/RLU.0000000000003505 Add to cart (remove)
	5.	124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods MedStar authors: Atkins, Francis Garcia, Carlos Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun 6 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Plyku D, Hobbs RF, Huang K, Atkins F, Garcia CA, Sgouros G, Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	6.	124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods MedStar authors: Atkins, Francis Garcia, Carlos Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Plyku D, Hobbs RF, Huang K, Atkins F, Garcia CA, Sgouros G, Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	7.	Survival rate in differentiated thyroid cancer patients with bone metastases. MedStar authors: Atkins, Francis Burman, Kenneth D Khorjekar, Gauri R Kulkarni, Kanchan Moreau, Shari Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Endocrinology Medicine/General Internal Medicine Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L Local accession number: 2014.1_132 Add to cart (remove)
	8.	Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based 3D radiobiological dosimetry (3D-RD) for 131I therapy of metastatic differentiated thyroid cancer (DTC) - organ dosimetry MedStar authors: Atkins, Francis Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Plyku D, Hobbs FR, Srinivasan S, Atkins F, Van Nostrand D, Sgouros G Local accession number: 2015_188 Add to cart (remove)
	9.	Does lemon juice increase radioiodine reaccumulation within the parotid glands more than if lemon juice is not administered?. MedStar authors: Atkins, Francis Kulkarni, Kanchan Mete, Mihriye Van Nostrand, Douglas Wartofsky, Leonard Wexler, Jason PMID: 24177041 Citation: Nuclear Medicine Communications. 35(2):210-6, 2014 Feb. Medline publication type: Clinical Trial Comparative Study Journal Article Form of publication: Journal Article All authors: Atkins F, Kulkarni K, Mete M, Van Nostrand D, Wartofsky L, Wexler J DOI: http://dx.doi.org/10.1097/MNM.0000000000000034 Add to cart (remove)
	10.	Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?. MedStar authors: Atkins, Francis Burman, Kenneth Garcia, Carlos Khorjekar, Gauri R Mete, Mihriye Moreau, Shari O'Neil, Jeff Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard PMID: 24820222 Citation: Thyroid. 24(9):1394-9, 2014 Sep. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Atkins FB, Burman K, Garcia C, Khorjekar GR, Mete M, Moreau S, O'Neil J, Orquiza MH, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.1089/thy.2013.0713 Add to cart (remove)

Powered by Koha